FemTech Leader Willow Acquires Elvie
2 minute read | April.02.2025

Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.
2 minute read | April.02.2025
Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.
2 minute read | June.12.2025
2 minute read | May.16.2025
This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent.
3 minute read | May.14.2025
Twist Bioscience Corporation has spun out its DNA data storage technology application as an independent company, named Atlas Data Storage.
3 minute read | May.07.2025
2 minute read | April.16.2025
Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.
On Thursday, May 16, 2024, Intellectual Property partner Irena Royzman will lead a presentation titled "Mandatory Clinical Trial Disclosures as Prior Art" at NJIPLA's 2024 Patent Litigation Seminar.
The New York Intellectual Property Law Association is hosting their event, “Biologics & Biosimilars: Hot Topics” in Orrick's NY office.
This on-demand CLE shares best practices and priority issues in overcoming regulatory hurdles for healthcare providers and facilities in telemedicine.